
Qubigen is an AI-driven drug design company that leverages a global federated AI system and computational toolbox to design novel, targeted medicines. Their federated AI approach allows for the secure utilization of diverse, protected data to gain insights without moving or sharing sensitive intellectual property. This technology enables faster drug design by reducing the time and resources needed to investigate poor candidate molecules, and generates high-quality drug candidates for specific protein targets. Qubigen's platform aims to shorten drug development timelines and reduce development risk by producing better quality candidates more quickly.

Qubigen is an AI-driven drug design company that leverages a global federated AI system and computational toolbox to design novel, targeted medicines. Their federated AI approach allows for the secure utilization of diverse, protected data to gain insights without moving or sharing sensitive intellectual property. This technology enables faster drug design by reducing the time and resources needed to investigate poor candidate molecules, and generates high-quality drug candidates for specific protein targets. Qubigen's platform aims to shorten drug development timelines and reduce development risk by producing better quality candidates more quickly.